Genetic Engineering and Genetic Disorders

Dr Sergey Suchkov, MD, PhD. Professor in Immunology & Medicine. Director, Center for Personalized Medicine, Sechenov University and Chair,Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Born on 11 Jan 1957, Astrakhan, Russia; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M.Sechenov First Moscow State Medical University, 1985; Doctor Degree, National Institute of Im-munology, Russia, 2001. Positions held: Post Doc Research Associate, Institute of Medical Enzymology; Head of the Lab of Immunology, Helmholtz Eye Research Institute in Moscow; Trainee, Laboratory of Immunology, NEI, Bethesda, MD, USA; Chair, Department for Clinical Immunology, Moscow Clinical Research Institute; Executive Secretary-in-Chief of the Editorial Board, Biomedical Science International journal. Honours: Secretary General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; ISPM, Tokyo, Japan; PMC, Washington, DC, USA; ACS, USA; AMEE, Dundee, UK; AHA, USA; EPMA, Brussels.

Medicine, Immunology Medicine, Immunology Clinical Immunology Immunology and medicine Medicine & Immunology Personalized Medicine

Magnus S. Magnusson, Research Professor, founder and director of the Human Behavior Laboratory, University of Iceland. PhD in 1983, University of Copenhagen. Author of the T-pattern model and detection software THEMETM (PatternVision.com), focused on real-time organization of behavior. Co-directed DNA analysis. Numerous papers and talks/keynotes in ethology, neuroscience, mathematics, religion, proteomics, mass spectrometry and nanoscience. Deputy Director 1983-1988, in Museum of Mankind, National Museum of Natural History, Paris. Repeatedly invited temporary Professor at the University of Paris, V, VIII and XIII. In collaboration between now nearly 40 universities initiated 1995 at University of Paris V, Sorbonne, based on “Magnusson’s analytical model”.

Genetic Disorders

Simon Berkovich has completed his PhD at the age of 27 years from the USSR Academy of Sciences. He played a leading role in a number of advanced research and development projects. He has several hundred prestigious professional publications in various areas of physics, electronics, computer science, and biological cybernetics. He is an author of six books and holds 30 patents. In 2002, he was elected a member of the European Academy of Sciences "for an outstanding contribution to computer science and the development of fundamental computational algorithms". In 2014, he won the GWU Technology Transfer Innovation Competition, patent is considered.

Genome Functionality, Information content of DNA, Organism’s development, Principle of requisite variety

Dr. Sukumar Saha has a total of thirty five years of professional research experience. He demonstrated outstanding stature and received significant recognition as an international authority in cotton genomics and cytogenetics for the development of genetic and cytogenetic resources that are being used by the scientists in the USA and around the world. He made a significant impact in three broad research areas: 1) molecular marker development and mapping, 2) interspecific chromosome substitution (CS) line development from G. barbadense, G. tomentosum and G. mustelinum and 3) a patent document submission to develop improved cotton lines using the emerging techniques of gene silencing. Dr. Saha in a collaborative project, developed, evaluated and released a unique set of backcrossed Gossypium barbadense (Pima 3-79) CS lines (CS-B) in a G. hirsutum background. These lines are near-isogenic with the exception of different substituted chromosomes from Pima 3-79. He also made a major contribution in developing SSR and SNP markers, a critical first step for the use of PCR-based marker technologies in the cotton breeding program. He was one of eight founding scientists of International Cotton Genome Initiative organization (ICGI), currently with over 600 members from the major cotton growing countries, to facilitate collaborative research work on cotton genomics and genetics at the global level. He was awarded the 2010 Cotton Geneticist award from the National Cotton Council of USA and ICAC Cotton Researcher of the year 2011 award by the International Cotton Advisory Committee. Dr. Saha’s research productivity is well documented in over 90 peer-reviewed journal articles, one germplasm release notice, a co-edited book, a patent document, additional multiple papers and abstracts in presentations at conferences. He is currently serving as the editor in chief of American Journal of Plant Sciences.

Genetics and Cytogenetics

Dr Khalid A. Fakhro is a Principal Investigator in Translational Medicine at Sidra Medical and Research Center in Qatar and Assistant Professor of Genetic Medicine at Weill Cornell Medical College in Qatar. He obtained a Bachelor’s degree with Honors in Cell Biology and Molecular Genetics from the University of Chicago and subsequently a Ph.D. in Human Genetics at Yale University, where he was part of a highly selective Howard Hughes Medical Scholars program focused on studying the molecular underpinnings of human disease. Dr. Fakhro has been pioneering research in human genomics and personalized medicine in Qatar, bringing along a decade of first-hand experience in high-throughput data generating platforms including a range of high-density genotyping microarrays and next-generation sequencing platforms, as well the use of multiple model organisms to study human disease. Currently, his work focuses on employing new genomics technologies to discover genes responsible for Mendelian disease and previously un-described congenital syndromes in the Qatari population. Dr Fakhro’s lab has also been awarded several large national grants for their work on human disease and population genomics in Qatar, where they focus on using new bioinformatics tools to analyze large-scale genomics data to describe variation, population structure and predisposition to disease from thousands of Qatari genomes and exomes. His work positions him at the intersection of basic science and clinical investigation, collaborating with many local stakeholders in Qatar to achieve the national health goals in personalized medicine.

Genomics technologies to discover genes responsible for Mendelian disease and previously un-described congenital syndromes,human disease and population genomics. Bioinformatics tools to analyze large-scale genomics data to describe variation, population structure and predisposition to disease.

Jan Lukas Robertus was appointed as a Consultant Cardiothoracic Pathologist at The Royal Brompton and Harefield NHS Foundation Trust in February 2015. He has previously worked as a Consultant Cardiothoracic Pathologist at the Erasmus Medical Centre, Rotterdam, the Netherlands. He is the lead pathologist for computational pathology. He is also co-lead for the Royal Brompton Cardiac Morphology UnJan Lukas Robertus, received his MD at the University of Utrecht and completed his PhD and registrar program in Pathology at the University of Groningen, the Netherlands. Heit and is member of the Brompton Cardiac Morphology Steering Committee. He is Honorary Senior Clinical Lecturer at the National Heart and Lung Institute, Imperial College London. His main research interests are computational pathology, specifically in the areas of thoracic oncology, cardiomyopathies, aortopathies, cardiac and pulmonary transplantation.

computational pathology